Injectable Anticoagulants Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anticoagulants Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 LMWH
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Anticoagulants Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Injectable Anticoagulants Market Perspective (2017-2028)
2.2 Injectable Anticoagulants Growth Trends by Region
2.2.1 Injectable Anticoagulants Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Injectable Anticoagulants Historic Market Size by Region (2017-2022)
2.2.3 Injectable Anticoagulants Forecasted Market Size by Region (2023-2028)
2.3 Injectable Anticoagulants Market Dynamics
2.3.1 Injectable Anticoagulants Industry Trends
2.3.2 Injectable Anticoagulants Market Drivers
2.3.3 Injectable Anticoagulants Market Challenges
2.3.4 Injectable Anticoagulants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Anticoagulants Players by Revenue
3.1.1 Global Top Injectable Anticoagulants Players by Revenue (2017-2022)
3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2017-2022)
3.2 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Anticoagulants Revenue
3.4 Global Injectable Anticoagulants Market Concentration Ratio
3.4.1 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anticoagulants Revenue in 2021
3.5 Injectable Anticoagulants Key Players Head office and Area Served
3.6 Key Players Injectable Anticoagulants Product Solution and Service
3.7 Date of Enter into Injectable Anticoagulants Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Anticoagulants Breakdown Data by Type
4.1 Global Injectable Anticoagulants Historic Market Size by Type (2017-2022)
4.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028)
5 Injectable Anticoagulants Breakdown Data by Application
5.1 Global Injectable Anticoagulants Historic Market Size by Application (2017-2022)
5.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Injectable Anticoagulants Market Size (2017-2028)
6.2 North America Injectable Anticoagulants Market Size by Country (2017-2022)
6.3 North America Injectable Anticoagulants Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Injectable Anticoagulants Market Size (2017-2028)
7.2 Europe Injectable Anticoagulants Market Size by Country (2017-2022)
7.3 Europe Injectable Anticoagulants Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Anticoagulants Market Size (2017-2028)
8.2 Asia-Pacific Injectable Anticoagulants Market Size by Country (2017-2022)
8.3 Asia-Pacific Injectable Anticoagulants Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Injectable Anticoagulants Market Size (2017-2028)
9.2 Latin America Injectable Anticoagulants Market Size by Country (2017-2022)
9.3 Latin America Injectable Anticoagulants Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Anticoagulants Market Size (2017-2028)
10.2 Middle East & Africa Injectable Anticoagulants Market Size by Country (2017-2022)
10.3 Middle East & Africa Injectable Anticoagulants Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Anticoagulants Introduction
11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Detail
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022)
11.2.5 Genentech (Roche) Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Aspen
11.4.1 Aspen Company Detail
11.4.2 Aspen Business Overview
11.4.3 Aspen Injectable Anticoagulants Introduction
11.4.4 Aspen Revenue in Injectable Anticoagulants Business (2017-2022)
11.4.5 Aspen Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Injectable Anticoagulants Introduction
11.5.4 Pfizer Revenue in Injectable Anticoagulants Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Hepalink
11.6.1 Hepalink Company Detail
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Injectable Anticoagulants Introduction
11.6.4 Hepalink Revenue in Injectable Anticoagulants Business (2017-2022)
11.6.5 Hepalink Recent Development
11.7 King-friend
11.7.1 King-friend Company Detail
11.7.2 King-friend Business Overview
11.7.3 King-friend Injectable Anticoagulants Introduction
11.7.4 King-friend Revenue in Injectable Anticoagulants Business (2017-2022)
11.7.5 King-friend Recent Development
11.8 CSBIO
11.8.1 CSBIO Company Detail
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Injectable Anticoagulants Introduction
11.8.4 CSBIO Revenue in Injectable Anticoagulants Business (2017-2022)
11.8.5 CSBIO Recent Development
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Detail
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022)
11.9.5 Amphastar Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Injectable Anticoagulants Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of LMWH
Table 3. Key Players of Unfractionated Heparin
Table 4. Key Players of Fibrinolytics
Table 5. Key Players of Others
Table 6. Global Injectable Anticoagulants Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Injectable Anticoagulants Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Injectable Anticoagulants Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Injectable Anticoagulants Market Share by Region (2017-2022)
Table 10. Global Injectable Anticoagulants Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Injectable Anticoagulants Market Share by Region (2023-2028)
Table 12. Injectable Anticoagulants Market Trends
Table 13. Injectable Anticoagulants Market Drivers
Table 14. Injectable Anticoagulants Market Challenges
Table 15. Injectable Anticoagulants Market Restraints
Table 16. Global Injectable Anticoagulants Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Injectable Anticoagulants Market Share by Players (2017-2022)
Table 18. Global Top Injectable Anticoagulants Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2021)
Table 19. Ranking of Global Top Injectable Anticoagulants Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Injectable Anticoagulants Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Injectable Anticoagulants Product Solution and Service
Table 23. Date of Enter into Injectable Anticoagulants Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Injectable Anticoagulants Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Table 27. Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Injectable Anticoagulants Revenue Market Share by Type (2023-2028)
Table 29. Global Injectable Anticoagulants Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Table 31. Global Injectable Anticoagulants Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Injectable Anticoagulants Revenue Market Share by Application (2023-2028)
Table 33. North America Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Injectable Anticoagulants Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Injectable Anticoagulants Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 43. Sanofi Company Detail
Table 44. Sanofi Business Overview
Table 45. Sanofi Injectable Anticoagulants Product
Table 46. Sanofi Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 47. Sanofi Recent Development
Table 48. Genentech (Roche) Company Detail
Table 49. Genentech (Roche) Business Overview
Table 50. Genentech (Roche) Injectable Anticoagulants Product
Table 51. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 52. Genentech (Roche) Recent Development
Table 53. Boehringer Ingelheim Company Detail
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Injectable Anticoagulants Product
Table 56. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. Aspen Company Detail
Table 59. Aspen Business Overview
Table 60. Aspen Injectable Anticoagulants Product
Table 61. Aspen Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 62. Aspen Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Injectable Anticoagulants Product
Table 66. Pfizer Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Hepalink Company Detail
Table 69. Hepalink Business Overview
Table 70. Hepalink Injectable Anticoagulants Product
Table 71. Hepalink Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 72. Hepalink Recent Development
Table 73. King-friend Company Detail
Table 74. King-friend Business Overview
Table 75. King-friend Injectable Anticoagulants Product
Table 76. King-friend Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 77. King-friend Recent Development
Table 78. CSBIO Company Detail
Table 79. CSBIO Business Overview
Table 80. CSBIO Injectable Anticoagulants Product
Table 81. CSBIO Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 82. CSBIO Recent Development
Table 83. Amphastar Pharmaceuticals Company Detail
Table 84. Amphastar Pharmaceuticals Business Overview
Table 85. Amphastar Pharmaceuticals Injectable Anticoagulants Product
Table 86. Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 87. Amphastar Pharmaceuticals Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Anticoagulants Market Share by Type: 2021 VS 2028
Figure 2. LMWH Features
Figure 3. Unfractionated Heparin Features
Figure 4. Fibrinolytics Features
Figure 5. Others Features
Figure 6. Global Injectable Anticoagulants Market Share by Application in 2021 & 2028
Figure 7. VTE Case Studies
Figure 8. ACS/MI Case Studies
Figure 9. AF Case Studies
Figure 10. Others Case Studies
Figure 11. Injectable Anticoagulants Report Years Considered
Figure 12. Global Injectable Anticoagulants Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Injectable Anticoagulants Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Injectable Anticoagulants Market Share by Region: 2021 VS 2028
Figure 15. Global Injectable Anticoagulants Market Share by Players in 2021
Figure 16. Global Top Injectable Anticoagulants Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Injectable Anticoagulants Revenue in 2021
Figure 18. North America Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Injectable Anticoagulants Market Share by Country (2017-2028)
Figure 20. United States Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Injectable Anticoagulants Market Share by Country (2017-2028)
Figure 24. Germany Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Injectable Anticoagulants Market Share by Region (2017-2028)
Figure 32. China Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Injectable Anticoagulants Market Share by Country (2017-2028)
Figure 40. Mexico Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Injectable Anticoagulants Market Share by Country (2017-2028)
Figure 44. Turkey Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Injectable Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 47. Genentech (Roche) Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 49. Aspen Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 50. Pfizer Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 51. Hepalink Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 52. King-friend Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 53. CSBIO Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 54. Amphastar Pharmaceuticals Revenue Growth Rate in Injectable Anticoagulants Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
